Experience

• 

  Trividia health, inc (formerly home diagnostics)

  Jan 2005 - Aug 2006

  Scientist

  Performed glucose sensor development for drugstore brand of diabetic test strips. Advanced method optimization efforts to support intellectual property generation.

• 

  R&d systems

  Sept 2006 - Nov 2013

  Manager, scientist

  Responsible for the product development, manufacturing, and QC of Proteome Profiler Array product line.

• 

  Bio-techne

  Nov 2013 - Mar 2024

  Established commercial vertical targeting cell and gene therapy production and stem cell research with simplified cell culture and characterization workflows. Oversaw enterprise-wide portfolio of GMP reagents and services with matrixed ownership of analytical instruments and consumables. Responsible for global immunoassay offering comprising RUO and IVD ELISA, OEM partnerships, multiplexed assays, and automated microfluidic ELISA. Directed product management, custom services, and development at two sites. Responsible for global immunoassay offering comprising RUO and IVD ELISA, OEM partnerships, multiplexed assays, and automated microfluidic ELISA. Directed product management, custom services, and development at two sites. Leader of product development and custom services for Analytical Solutions Division across three sites. Directed the global strategy for Bio-Techne’s immunoassay business with emphasis on commercial and new product development activities. Directly managed leaders of product development and product management teams and worked closely with operations, quality, and regional commercial leaders. Contributed to integration of recent acquisitions, CyVek and Trevigen. Expanded custom services team spanning assay development to clinical sample testing and implemented LIMS and sample handling robotics. Managed the immunoassay product development teams responsible for development and validation of ELISA and Proteome Profiler Array platforms. Collaborated with downstream protein and antibody teams to develop optimal assay reagents. Product definition, development, validation, and transfer to operations and QC completed using design controls in ISO 9001 environment.

  • Vice President, Enterprise Cell & Gene Therapy

    Oct 2021 - Mar 2024

  • Vice President, Immunoassay Business Unit

    Mar 2021 - Oct 2021

  • Senior Director, ELISA Business Unit

    Aug 2019 - Mar 2021

  • Senior Director, Product Development

    Jul 2018 - Aug 2019

  • Senior Director, Assay Business Unit

    Jul 2016 - Jul 2018

  • Director, Assay Development

    Nov 2013 - Jun 2016
• 

  Donaldson

  Jun 2024 - now

  Life sciences program management

  Vehicle Electrification, Food & Beverage, Bioprocessing, & Medical Device